Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedLocations section reorganized into a consolidated Locations section, removing the prior per-state headings (California, Florida, Kansas, New Jersey, Ohio, Oregon) and updating the revision to v3.3.3.SummaryDifference0.7%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedPage revision tag updated from v3.2.0 to v3.3.2; no user-facing content or study details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedThe government funding/operating status notice was removed from the page; it was informational and not part of the study details.SummaryDifference0.3%

- Check61 days agoChange DetectedResults for the study NCT03547999 have been posted on ClinicalTrials.gov. The record now shows a Results First Posted date of 2025-07-22 along with the associated outcome measures.SummaryDifference0.4%

- Check90 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check97 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.